Digital Transformation in Biomanufacturing – Insights from Treehill Partners in The Pharma Navigator
Our Partner Max Baumann recently contributed to an expert panel discussion with The Pharma Navigator on how digital tools are reshaping biomanufacturing processes.
Key insights shared by Treehill Partners:
On Digital Twins and Process Optimization: While digital twins and advanced modeling tools are becoming standard in new-build facilities from leading providers, adoption varies across the industry. Where implemented effectively, these technologies are delivering reduced batch failures, improved product quality, and enhanced regulatory compliance through automated documentation and monitoring.
Scale-Up Challenges: Scale-up has traditionally been capital-intensive and often treated as an afterthought after achieving clinical proof-of-concept. Over the next decade, scale-up simulations are expected to enable smaller manufacturers to accurately translate lab-scale results to commercial production, minimizing costly surprises and better preparing both assets and organizations for the commercial marketplace.
The Workforce Evolution: The shift to AI-integrated biomanufacturing requires a fundamental rethinking of organizational processes. The challenge is not just individual skill development — it is building coordinated, repeatable, and auditable AI-based workflows where teams leverage technology collectively rather than in isolated desktop applications. True digital maturity comes from transforming AI from a product into a collective organizational competency.
Read the full article featuring perspectives from industry leaders at Autolomous, Bionova Scientific, Cellular Origins, FUJIFILM Biotechnologies, and Treehill Partners: Optimizing Biomanufacturing with Digital Tools